From Our Perspective: FDA’s Role in Helping a Critical Medical Isotope Meet Sufficient Supply in the US for First Time

Recently FDA’s Center for Drug Evaluation and Research (CDER) and the U.S. Department of Energy’s (DOE) National Nuclear Security Administration (NNSA) recognized that the U.S. has reached a sufficient supply of Molybdenum 99 (Mo-99).
Category: News